New Market Report Now Available: Cambodia Pharmaceuticals & Healthcare Report Q4 2010

Oct. 18, 2010 - PRLog -- In our Q410 Pharmaceutical Business Environment Ratings, Cambodia is last of the 17 pharmaceutical markets surveyed in the Asia Pacific region, with its situation unlikely to improve in the coming months. Transparency International rates the country as the fourth most corrupt in Asia, with only Laos, Myanmar and Afghanistan faring worse. Failure to address these structural issues will bode poorly for long-term growth and development.

Additionally, Minister of Commerce Cham Prasidh said on August 24 2010 that the government's decision to introduce competition laws in Cambodia has been deferred. He said the government will wait until 2011 to consider whether to implement the legislation, although a finalised draft version has been completed. The Association of Southeast Asian Nations (ASEAN)'s member states have been given until 2015 to comply with regional guidelines on competition policy. We are concerned that failure to meet the deadline may deter foreign companies from expanding in Cambodia as they await the finalisation of the competition laws.

In positive news, a US$5.9bn action plan that covers the development of physical infrastructure and trade facilitation in five Mekong countries (Cambodia, Vietnam, Laos, Thailand and Myanmar) was approved in August. Cham Prasidh said on August 26 that Cambodia and Laos may get the most financing support for infrastructure development when the countries start implementing the plan in October. We believe the plan will lead to a significant increase in trade between the Mekong countries over the coming years and speed up economic development in Cambodia.

A decade of economic growth and political stability has allowed Cambodia to begin to tackle its underdeveloped healthcare system. Measures such as health equity funds, a new social health insurance system and the use of nongovernmental organisations (NGOs) have begun to reduce inequalities in the system. The public health budget has grown in line with economic growth. However, per capita health expenditure remains low and around 60% of healthcare costs are paid out-of-pocket.

Cambodia's pharmaceutical market was calculated to be worth KHR711bn (US$172mn) in 2009. In 2010, we calculate that pharmaceutical expenditure will reach a value of KHR815bn (US$194mn). BMI forecasts drug consumption to increase at a compound annual growth rate (CAGR) of 10.8% in local currency terms and 11.04% in US dollar terms over the next five years to reach a value of KHR1,185bn (US$291mn) in 2014. Our long-range forecast is for the market to reach KHR1,901bn (US$475mn) in 2019, equivalent to a CAGR of 10.3% in local currency terms and 10.7% in US dollar terms over the 10- year period.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/88525_cambodia_pharmaceuticals...

Report Table of Contents:

SWOT Analysis
- Cambodia Pharmaceuticals And Healthcare Industry SWOT
Pharmaceutical Business Environment Ratings
- Table: Asia Pacific Pharmaceutical Business Environment Ratings, Q410
- Rewards
- Risks
Cambodia - Market Summary
- Historical Data & Forecasts
Regulatory Regime
- Intellectual Property Environment
- Counterfeit Medicine
- Pricing And Reimbursement
Industry Trends and Developments
- Epidemiology
- Healthcare Sector
- Health Insurance
- Pharmaceutical Wholesale
- Pharmaceutical Retail
- Research & Development Sector
- Clinical Trials
- Medical Devices
Industry Forecast Scenario
- Pharmaceutical Market Forecast
- Healthcare Market Forecast
- Pharmaceutical Trade Forecast
- Medical Devices Forecast
- Key Risks To BMI's Forecast Scenario
Competitive Landscape
- Pharmaceutical Industry
- Pharmaceutical Company Developments
Company Profiles
- Indigenous Companies
- PharmaProduct Manufacturing
- Cambodia Pharmaceutical Enterprises
- Multinational Companies
- Sanofi-Aventis
- Pfizer
Country Snapshot: Cambodia Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market And Spending Power
- Table: Employment Indicators, 2000-2004
- Table: Consumer Expenditure, 2000-2009 (US$mn)
- Table: Average Annual Manufacturing Wages, 1996-2001
BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceutical Business Environment Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
Forecast Tables

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.